The maximum tumor growth rate predicts clinical outcomes of patients with small‐cell lung cancer undergoing first‐line chemotherapy plus immune‐checkpoint inhibitor therapy

BACKGROUND: Currently, no biomarkers can accurately predict survival outcomes in patients with SCLC undergoing treatment. Tumor growth rate (TGR; percent size change per month [%/m]) is suggested as an imaging predictor of response to anti‐cancer treatment. We aimed to evaluate the predictive role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiang, Chen, Xueyuan, Liu, Tingting, Zhou, Ting, Chen, Gang, Zhou, Huaqiang, Huang, Yan, Fang, Wenfeng, Yang, Yunpeng, Zhou, Ningning, Chen, Likun, Mo, Silang, Zhang, Li, Zhao, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134330/
https://www.ncbi.nlm.nih.gov/pubmed/36629288
http://dx.doi.org/10.1002/cam4.5611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134330/
https://www.ncbi.nlm.nih.gov/pubmed/36629288
http://dx.doi.org/10.1002/cam4.5611

Ejemplares similares